Whether your personal interests are in supporting innovation, bringing lifesaving biomedical products to patients, training the next generation of biomedical leaders or fueling our economy, the Center for Biotechnology provides a vehicle to accomplish great things. Things that matter. Things that change, and save, lives.
Your involvement is an essential part of our future. Please consider a gift to the Center for Biotechnology which will help fuel innovation by ensuring that lifesaving technologies make it out of research labs and into the hands of patients.
Give to the Center for Biotechnology online through the Stony Brook Foundation. Contributions can be made to our Fund for Excellence. More information about donating through the Stony Brook Foundation can be found here.
IO360˚ convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers. The 6th annual Immuno-Oncology 360° Summit is the premier meeting across all stakeholders in IO, addressing the rapid advancements of clinical, scientific and business developments of IO in one setting to help develop therapeutics for a wider range of cancers at an accelerated rate.
The 3 day summit features more than 80 time sensitive IO topics, over 500 senior level thought leaders and includes over 10 hours of networking. Use the code CFB20 for a 20% discount. For more information please visit: www.io360summit.com
Applications are now open for the 12th BioREACH Award Program from the Center for Biotechnology, which provides $50,000 in translational research funding for Stony Brook faculty and postdoctoral researchers to generate the evidence needed to advance promising innovations to the next stage of development.
BioREACH funds milestone-driven studies and welcomes biomedical innovations as well as platforms, tools, computational technologies, and other enabling technologies with the potential to contribute to solutions addressing unmet needs in health.
Application deadline: October 29, 2026, 5:00pm ET
For info sessions, eligibility and deadlines visit our REACH Website and FAQ.
The Center for Biotechnology (CfB) has helped advance some of Stony Brook University’s most impactful biomedical innovations, among them the yeast two-hybrid system, Xiaflex®, ReoPro®, Oracea®, and 3D virtual colonoscopy. The CfB has supported more than 475 faculty-led translational research projects and contributed to 306 license agreements generating $51 million in royalty returns to the University.
Questions? Reach out to our program contacts or sign up for office hours:
The Life Sciences Innovation and Entrepreneurship (LiSIE) program at Stony Brook is looking to give students a jump-start in the bioscience industry. The program is a joint effort between the Department of Biomedical Engineering in the College of Engineering and Applied Sciences, the College of Business and the Center for Biotechnology. “From the lab to leadership”, the program aims to teach key business principles to life sciences students so they’re equipped to work in the business side of science.
Read the recent SBU News feature on the program and the CFB Appointed Director Director of the Program in Life Sciences Innovation and Entrepreneurship, Dr. Louis A. Peña.
In early February, we welcomed leadership from Empire State Development (ESD), including its Division of Science, Technology and Innovation (NYSTAR) and New York Ventures, for a two-day visit focused on applied research, industry collaboration and economic development across New York State.
The visit spotlighted key teams throughout Stony Brook University, including the Center’s role in driving innovation through supporting hundreds of patents, licenses, and commercialization efforts to help translate breakthrough discoveries into real‑world medical and biotechnology applications. As our very own Clinton Rubin remarked, "We are excited by NYS’s commitment to harnessing Stony Brook’s research enterprise for economic impact, and building the life sciences innovation and entrepreneurship ecosystem here on campus, on Long Island and in our State.”
We’re excited to share more soon about how our Center is bringing its vision to life by accelerating the path from academic research to marketplace solutions.
[post_title] => NYSTAR Visits SBU
[post_excerpt] =>
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => nystar-visits-sbu
[to_ping] =>
[pinged] =>
[post_modified] => 2026-03-09 13:25:51
[post_modified_gmt] => 2026-03-09 17:25:51
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://centerforbiotechnology.org/?p=4929
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[3] => WP_Post Object
(
[ID] => 190
[post_author] => 4
[post_date] => 2013-07-12 13:19:13
[post_date_gmt] => 2013-07-12 13:19:13
[post_content] => Xiaflex, a drug developed, in part, with support by the Center for Biotechnology, has received a second approval for the treatment of men with Peyronie's disease, a painful curvature of the penis due to the buildup of plaque. The drug is already approved for the treatment of Depuytren's contracture, a condition that causes contraction of the fingers. Additional applications under development include frozen shoulder and cellulite. The drug is marketed by Auxilium. Read more here.
[post_title] => Advancing Ideas into Reality
[post_excerpt] => Candy that fights cavities. Vibrating away bone loss. A virtual colonoscopy. The Center for Biotechnology has helped accelerate the development of academic technologies into products that will benefit human health.
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => oldies-but-goodies
[to_ping] =>
[pinged] =>
[post_modified] => 2014-09-02 18:44:48
[post_modified_gmt] => 2014-09-02 18:44:48
[post_content_filtered] =>
[post_parent] => 0
[guid] => http://centerforbiotechnology.org/new/?p=190
[menu_order] => 231
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
)
[post_count] => 4
[current_post] => -1
[before_loop] => 1
[in_the_loop] =>
[post] => WP_Post Object
(
[ID] => 5065
[post_author] => 4
[post_date] => 2026-09-01 14:03:32
[post_date_gmt] => 2026-09-01 18:03:32
[post_content] =>
Applications are now open for the 12th BioREACH Award Program from the Center for Biotechnology, which provides $50,000 in translational research funding for Stony Brook faculty and postdoctoral researchers to generate the evidence needed to advance promising innovations to the next stage of development.
BioREACH funds milestone-driven studies and welcomes biomedical innovations as well as platforms, tools, computational technologies, and other enabling technologies with the potential to contribute to solutions addressing unmet needs in health.
Application deadline: October 29, 2026, 5:00pm ET
For info sessions, eligibility and deadlines visit our REACH Website and FAQ.
The Center for Biotechnology (CfB) has helped advance some of Stony Brook University’s most impactful biomedical innovations, among them the yeast two-hybrid system, Xiaflex®, ReoPro®, Oracea®, and 3D virtual colonoscopy. The CfB has supported more than 475 faculty-led translational research projects and contributed to 306 license agreements generating $51 million in royalty returns to the University.
Questions? Reach out to our program contacts or sign up for office hours:
